Core Laboratories Inc expected to post earnings of 19 cents a share - Earnings Preview

Core Laboratories

21/07/2025 21:05

Core Laboratories Inc CLB.N, CLB is expected to  show a fall in quarterly revenue when it reports  results on July 23 for the period ending June 30 2025

The Houston Texas-based  company is expected to report a 1.3% decrease in revenue to $128.841 million from $130.58 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on April 23 2025, for the period ended June 30, was for revenue between $128.00 million and $134.00 million.

​LSEG's mean analyst estimate for Core Laboratories Inc is for earnings of 19 cents per share. The company's EPS guidance on April 23 2025, for the period ended June 30, was between $0.17 and $0.21

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Core Laboratories Inc is $13.00, about 12.3% above its last closing price of $11.40

The company's guidance on April 23 2025 for the period ended June 30 was for Earnings before Interest and Taxes between USD13.1 million and USD15.7 million.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
0.15
0.15
0.14
Missed
-3.7
Dec. 31 2025
0.22
0.22
0.22
Met
0.7
Sep. 30 2024
0.23
0.23
0.25
Beat
8.2​
Jun. 30 2024
0.21
0.21
0.22
Beat
6.6
​​Mar. 31 2024
0.16
0.16
0.19
Beat
21.7
Dec. 31 2023
0.19
0.19
0.19
Met
-1.3​
Sep. 30 2023
0.22
0.22
0.22
Met
-0.1
Jun. 30 2023
0.20
0.20
0.21
Beat
5.3

This summary was machine generated July 21 at 20:05 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)